Medicare Enrolled

Dr. Thomas Leist, M.D.

Neurology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
900 WALNUT ST, Philadelphia, PA 19107
2159556871
Registered in NPPES since 2006
NPI: 1801816681 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leist from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leist? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leist

Dr. Thomas Leist is a neurology specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leist performed 637 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Leist received a total of $1,645,316 from 35 pharmaceutical and/or device companies across 1388 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leist is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 22% volume in PA $1,645,316 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
637
Medicare services
Top 22% in PA for neurology
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
191 $110 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
144 $53 $190
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
128 $69 $275
Nursing facility visit, high complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes.
51 $127 $260
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
40 $87 $155
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 22 $30 $91
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
17 $86 $300
New patient office visit, complex (60-74 min) 16 $133 $425
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
16 $152 $315
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $101 $245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,645,316
Total received (2018-2024)
Avg $235,045/year across 7 years
Top 0% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
1,388
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$135,170
2023
$181,943
2022
$142,480
2021
$145,612
2020
$183,316
2019
$525,261
2018
$331,534

Payments by company (2024)

Amgen Inc.
$50,393
Genentech USA, Inc.
$28,210
TG Therapeutics, Inc.
$17,278
GENZYME CORPORATION
$13,160
Biogen, Inc.
$10,159
Alexion Pharmaceuticals, Inc.
$8,151
EMD Serono, Inc.
$5,186
Novartis Pharmaceuticals Corporation
$2,050
Celgene Corporation
$272
ABBVIE INC.
$234
Vanda Pharmaceuticals Inc.
$55
Merz Pharmaceuticals, LLC
$21
Top 3 companies account for 70.9% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$288,364
EMD Serono, Inc.
$264,109
Celgene Corporation
$230,949
GENZYME CORPORATION
$179,641
Genentech USA, Inc.
$147,571
Horizon Therapeutics plc
$88,453
E.R. Squibb & Sons, L.L.C.
$67,941
Novartis Pharmaceuticals Corporation
$63,483
Teva Pharmaceuticals USA, Inc.
$52,547
Amgen Inc.
$50,414
Alexion Pharmaceuticals, Inc.
$37,625
SANOFI-AVENTIS U.S. LLC
$26,456
TG THERAPEUTICS, INC.
$24,467
TG Therapeutics, Inc.
$22,296
F. Hoffmann-La Roche AG
$22,286
Genentech, Inc.
$14,668
NOVARTIS PHARMACEUTICALS CORPORATION
$13,594
Actelion Clinical Research, Inc.
$9,972
Actelion Pharmaceuticals, Ltd
$9,906
Janssen Global Services, LLC
$9,323
Janssen Pharmaceuticals, Inc
$6,005
Novartis Pharma AG
$5,656
Hoffmann-La Roche Limited
$4,000
Janssen Scientific Affairs, LLC
$3,240
Merck KGaA
$820
Bayer HealthCare Pharmaceuticals Inc.
$674
ABBVIE INC.
$510
ANI Pharmaceuticals, Inc.
$85
Lilly USA, LLC
$75
Sumitomo Pharma America, Inc.
$57
Vanda Pharmaceuticals Inc.
$55
IDORSIA PHARMACEUTICALS US INC
$23
Merz Pharmaceuticals, LLC
$21
Acorda Therapeutics, Inc
$17
Ipsen Biopharmaceuticals, Inc
$14
Top 3 companies account for 47.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · ALTUVIIIO · AMPYRA · AUBAGIO · AVONEX · Aimovig · BRIUMVI · Betaseron · COPAXONE · DISEASE STATE · Dysport · EMGALITY · Enspryng · Evobrutinib · GEMTESA · GILENYA · KESIMPTA · LEMTRADA · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NO PRODUCT DISCUSSED · OCREVUS · OMB157A · OMB157B · Ocrevus · Ozanimod · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · Rebif · SOLIRIS · Soliris · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Philadelphia?
Compare neurologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
516
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Leist is a clinical cardiology specialist, with above-average Medicare volume (top 22% in PA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Leist experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Leist performed 191 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Leist receive payments from pharmaceutical companies?
Yes. Dr. Leist received a total of $1,645,316 from 35 companies across 1,388 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leist's costs compare to other neurologists in Philadelphia?
Dr. Leist's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leist) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →